Sequestration of the Transcription Factor STAT3 by the Molecular Chaperone CCT: A Potential Mechanism for Modulation of STAT3 Phosphorylation

被引:13
|
作者
Vallin, Josefine [1 ]
Cordoba-Beldad, Carmen M. [1 ]
Grantham, Julie [1 ]
机构
[1] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden
关键词
protein folding; TRiC; chaperonin; Interleukin-6; sequester; EUKARYOTIC CHAPERONIN; CYTOSOLIC CHAPERONIN; PROTEIN GELSOLIN; BETA-ACTIN; IN-VIVO; SUBUNITS; TUBULIN; PATHWAY;
D O I
10.1016/j.jmb.2021.166958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chaperonin Containing Tailless complex polypeptide 1 (CCT) is an essential molecular chaperone required for the folding of the abundant proteins actin and tubulin. The CCT oligomer also folds a range of other proteins and participates in non-folding activities such as providing assembly support for complexes of the von Hippel Lindau tumor suppressor protein and elongins. Here we show that the oncogenic transcription factor STAT3 binds to the CCT oligomer, but does not display the early binding upon translation in rabbit reticulocyte lysate typical of an obligate CCT folding substrate. Consistent with this, depletion of each of the CCT subunits by siRNA targeting indicates that loss of CCT oligomer does not suppress the activation steps of STAT3 upon stimulation with IL-6: phosphorylation, dimerisation and nuclear translocation. Furthermore, the transcriptional activity of STAT3 is not negatively affected by reduction in CCT levels. Instead, loss of CCT oligomer in MCF7 cells leads to an enhancement of STAT3 phosphorylation at Tyr705, implicating a role for the CCT oligomer in the sequestration of non-phosphorylated STAT3. Thus, as CCT is dynamic oligomer, the assembly state and also abundance of CCT oligomer may provide a means to modulate STAT3 phosphorylation. (C) 2021 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
    Lee, David S.
    O'Keefe, Rachel A.
    Ha, Patrick K.
    Grandis, Jennifer R.
    Johnson, Daniel E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [42] STAT3 transcription factor as target for anti-cancer therapy
    Aliaa M. Mohassab
    Heba A. Hassan
    Dalia Abdelhamid
    Mohamed Abdel-Aziz
    Pharmacological Reports, 2020, 72 : 1101 - 1124
  • [43] Transcription factor Stat3 promotes metastatic progression of prostate cancer
    Gu, Lei
    Abdulghani, Junaid
    Dagvadorj, Ayush
    Lutz, Jacqueline
    Bonuccelli, Gloria
    Lisanti, Michael P.
    Zellweger, Tobias
    Alanen, Kalle
    Mirtti, Tuomas
    Visakorpi, Tapio
    Bubendorf, Lukas
    Nevalainen, Marja T.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 392 - 392
  • [44] STAT3 transcription factor as target for anti-cancer therapy
    Mohassab, Aliaa M.
    Hassan, Heba A.
    Abdelhamid, Dalia
    Abdel-Aziz, Mohamed
    PHARMACOLOGICAL REPORTS, 2020, 72 (05) : 1101 - 1124
  • [45] Transcription Factor STAT3 As a Prognostic Marker and Therapeutic Target in Cancer
    Frank, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4560 - 4561
  • [46] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    CELL, 1999, 98 (03) : 295 - 303
  • [47] STAT3 on the brain
    不详
    NATURE REVIEWS CANCER, 2018, 18 (08) : 468 - 468
  • [48] The regulatory relationship between transcription factor STAT3 and noncoding RNA
    Siyi Liu
    Wentao Li
    Lin Liang
    Yanhong Zhou
    Yanling Li
    Cellular & Molecular Biology Letters, 29
  • [49] Transcription factor STAT3 in leptin target neurons of the rat hypothalamus
    Häkansson, ML
    Meister, B
    NEUROENDOCRINOLOGY, 1998, 68 (06) : 420 - 427
  • [50] The regulatory relationship between transcription factor STAT3 and noncoding RNA
    Liu, Siyi
    Li, Wentao
    Liang, Lin
    Zhou, Yanhong
    Li, Yanling
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)